Overview

Pre-emptive Dexamethasone in Hip Arthroplasty

Status:
Recruiting

Trial end date:
2021-11-22

Target enrollment:
0

Participant gender:
All

Summary

- Certain studies suggested that preoperative administration of systemic glucocorticoids in patients undergoing hip or knee arthroplasty surgery may improve the postoperative analgesia owing to their anti-inflammatory effect. - This study will be carried out on 70 adult patients aged 21 to 75 years admitted to orthopedic operating rooms in Tanta university hospitals for hip surgery under spinal anesthesia. Informed written consent will be obtained from each participant. - Patients will be randomly distributed into two equal groups using the computer-generated software. - Control Group: (35 patients) Those patients will receive 10 ml of normal saline before surgery. - Dexamethasone Group: (35 patients) Those patients will receive 16 mg dexamethasone in 10 ml of normal saline before surgery. - Primary outcome will be postoperative morphine consumption and the secondary outcome will be the postoperative pain score

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Tanta University

Treatments:

Dexamethasone

Criteria

Inclusion Criteria:

- Patients ASA II and III, aged 21 to 75 years, admitted for hip arthroplasty surgery

Exclusion Criteria:

- Patients who refused to participate in the research

- Suspected or diagnosed coagulopathy

- Allergy to bupivacaine

- With major cardiac, renal, or hepatic disorders